Interview: Francesco di Marco – General Manager, Amgen Italy
Francesco di Marco, General Manager for Amgen Italy, shares his view on the state of the Italian pharmaceutical sector, the turnaround the company has made in the country, and what…
German-Italian Chamber of Commerce – The Business Platform for Italy
The German-Italian Chamber of Commerce (AHK Italien) belongs to the network of 130 German Chambers of Commerce in 90 countries around the world. Its function is to support the economic activities between Germany and Italy.
With around 600 members in Germany and Italy, the German-Italian Chamber of Commerce is a bilateral business association and a platform for networking, enjoying high consideration in the political and economic environment in both countries.
Through its service company, DEinternational Italia Srl, the Chamber offers high quality services to companies of both countries. Each year about 5,000 requests are processed, about 1,000 regular customers are assisted and about 100 Italian and German companies are introduced into the respective foreign market. The services are based on decades of experience in consulting and supporting companies in their internationalization process. High-level professional services meet high standards of content and quality and are systematically updated and developed further.
The cooperation with the worldwide network of German Chambers of Commerce allows the realization of international projects in various markets at the same time.
Contact Details
German-Italian Chamber of Commerce
Via Gustavo Fara,
26 20124
Milano
Tel.:+39 02 679131
Fax:+39 02 66980964
info@ahk-italien.it
www.ahk-italien.it
Francesco di Marco, General Manager for Amgen Italy, shares his view on the state of the Italian pharmaceutical sector, the turnaround the company has made in the country, and what…
Galderma Italy was a founding European affiliate for the company and has seen incredible growth in the past two decades. Managing Director Bernat Albinyana discusses the affiliate’s performance, its business…
Dr. Ermano Buratti, General Manager for Astellas Pharma in Italy, discusses the company’s evolution as it enters its second decade, the importance of partnering with the government on reimbursement, the…
In 2008 Focus Reports interviewed Mr. Federico Seghi Recli as he prepared to transform Molteni Farmaceutici into an International specialty pharma company. Today we catch up on the progress, investments…
The General Manager for Eli Lilly Italy, discusses how the company’s continuous commitment to Italy has benefited the organization, the promise the country holds if certain barriers can be overcome, and how Lilly’s…
The CEO of MSD Italy discusses the company’s promising pipeline, its plans to realize growth through the launch of innovative new drugs in 2016, the paths towards a sustainable healthcare…
The MD of the Spanish Chamber of Commerce in Italy takes stock of the prevailing business winds between the two countries as both economies complete their emergence from the shadow of…
Massimo Visentin, Country Leader for Pfizer Italy, discusses the company’s remarkable success in 2015, his hopes and ambitions for the new year, and the need of the industry and Pfizer…
Prof. Luigi Naldini, Director of TIGET, discusses the success of the institute and the groundbreaking partnerships it has formed with the pharmaceutical industry, as well as his ambitions for TIGET…
Pasquale Frega, General Manager for Celgene Italy, discusses the company’s rapid growth and imminent entry into immunology, the business and regulatory environment for innovators in the country and the characteristics…
Dr. Costas Piliounis discusses the importance of containing diabetes, the dampening effects budget ceilings have on companies’ performance and growth potential, as well as the positive influence which changes currently…
Chris Juliam, Managing Director for Takeda Italy, shares the strategy the company is pursuing in the country, the effects market-access issues are having on innovators and patients, and what new…
See our Cookie Privacy Policy Here
